| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 460,237 | 527,217 | 538,136 | 631,870 | | Cost of Revenue | 223,421 | 141,320 | 372,599 | 497,565 | | | Gross Profit | 236,816 | 385,897 | 165,537 | 134,305 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 243,878 | 336,319 | 158,102 | 172,735 | | Non Recurring | 14,746 | 7,768 | 8,705 | 70,186 | | Others | 18,260 | 39,274 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (40,068) | 2,536 | (1,270) | (108,616) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,462 | 7,596 | 4,449 | 1,247 | | Earnings Before Interest And Taxes | (38,606) | 10,132 | 3,179 | (107,369) | | Interest Expense | 4,822 | 4,485 | 5,020 | 2,053 | | Income Before Tax | (43,428) | 5,647 | (1,841) | (109,422) | | Income Tax Expense | 4,934 | 664 | 4,720 | (971) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (48,362) | 4,983 | (6,561) | (108,451) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (48,362) | 4,983 | (6,561) | (108,451) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($48,362) | $4,983 | ($6,561) | ($108,451) |
|
0.31% Nasdaq 
0.05%
Income Statement
